Bookmark

Add to MyYahoo RSS

AstraZeneca Group News

News on AstraZeneca Group (Ticker: AZN) continually updated from thousands of sources around the net.

1 hr ago | Investor's Business Daily

Pfizer, Merck, Amgen Near Q2 Earnings Reports

In his downgrade note Monday, BMO Capital Markets analyst Alex Arfaei noted that patent expirations are going to continue through next year.

Comment?

Related Topix: Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Arthritis, Health

14 hrs ago | Hispanic Business

AstraZeneca and QIAGEN enter collaboration to develop diagnostic test ...

IRESSA is an epidermal growth factor receptor tyrosine kinase inhibitor that blocks the signals from the EGFR, which leads to tumour growth.

Comment?

Related Topix: Biotech, Health, Lung Cancer

14 hrs ago | Hispanic Business

AstraZeneca and Roche announce partnership to develop companion diagnostic test for AZD9291

The companion diagnostic test is designed to identify epidermal growth factor receptor mutations in both tumour tissue and plasma derived from patients with NSCLC, and to optimise the clinical development of AZD9291 for patients who are resistant to first -generation EGFR tyrosine kinase inhibitors .

Comment?

Related Topix: Biotech, Health, Lung Cancer

Tue Jul 22, 2014

Hispanic Business

Advaxis and MedImmune Partner on Immuno-Oncology Combination Clinical Trial

The Phase I/II immunotherapy study will evaluate the safety and efficacy of lead cancer immunotherapy vaccine, ADXS-HPV, as a treatment for patients with advanced, recurrent or refractory human papillomavirus -associated cervical cancer and HPV-associated head and neck cancer.

Comment?

Related Topix: HPV, Health, Oncology, Medicine, Biotech, MedImmune, Healthcare Industry, Vaccinations, Cervical Cancer

Fri Jul 18, 2014

BioSpace

AstraZeneca PLC Unveils Plans For "See-Through" Labs In Cambridge

The days of secretive drug research will soon be a distant memory for the scientists at one of Britain's biggest pharma companies.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

Live Charts

Broker tips: GlaxoSmithKline, AstraZeneca, Housebuilders

Panmure Gordon said it is "not expecting fireworks" from GlaxoSmithKline's second-quarter results due out next Wednesday.

Comment?

Related Topix: Biotech, GlaxoSmithKline

Thu Jul 17, 2014

Seeking Alpha

Xalkori: Pfizer's Lung Cancer Drug Might Get A Future Boost In Sales

It is no secret that Pfizer has had a rocky first half this year. The difficulties around its attempt to acquire AstraZeneca were compounded by Q1 sales that missed market expectations by 9 percent.

Comment?

Related Topix: Medicine, Cancer, Health, Lung Cancer, Pfizer, Biotech, Healthcare Industry, AstraZeneca, Oncology

Wed Jul 16, 2014

AmericanBankingNews.com

AstraZeneca plc Receives "Buy" Rating from Citigroup Inc.

's stock had its "buy" rating reiterated by equities research analysts at Citigroup Inc. in a research note issued to investors on Wednesday.

Comment?

Related Topix: Biotech

GuruFocus.com

I Believe AstraZeneca Is Fairly Valued

AstraZeneca PLC , a $94.71 billion market cap company is a giant in the drug industry and has a trailing P/E ratio that indicates that the stock is relatively undervalued .

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

Customer Interaction Solutions

Alexion Announces the Appointments of David R. Brennan, M. Michele...

Alexion Pharmaceuticals, Inc. today announced the appointments of David R. Brennan, M. Michele Burns and Christopher J. Coughlin to the Company's Board of Directors, effective immediately.

Comment?

Related Topix: Alexion Pharmaceuticals, Biotech, Medicine, Healthcare Industry, AstraZeneca, Merck , Insurance, Marsh and Mclennan Companies

Seeking Alpha

Walgreen Tax Inversion: Masking A Weak Business?

Walgreen shares are trading near an all-time high and at a fancy multiple for a drug store chain - a forward PE ratio of more than 20 - as investors focus on whether the company will engage in a tax inversion as part of its expected acquisition of the 55% of Alliance Boots, the European drug store chain, not already owned by Walgreen.

Comment?

Related Topix: Walgreens, Retail, Pfizer, Biotech, Medicine, Healthcare Industry, AstraZeneca, Rite Aid

Tue Jul 15, 2014

MarketWatch

U.S. 'inversion' takeovers strike fear in Europe

Bankers in Europe say their clients are concerned about being taken over by U.S. companies as the trend of so-called inversion deals continues.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry, Shire plc

AmericanBankingNews.com

AstraZeneca plc Given Average Recommendation of "Hold" by Analysts

AstraZeneca plc has earned a consensus rating of "Hold" from the twenty-two analysts that are currently covering the stock, AnalystRatings.NET reports .

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

AmericanBankingNews.com

AstraZeneca plc PT Lowered to GBX 4,790

The firm currently has a "hold" rating on the stock. Jefferies Group's target price would suggest a potential upside of 9.62% from the stock's previous close.

Comment?

Related Topix: Biotech

Mon Jul 14, 2014

Seeking Alpha

Medtronic Not Sticking Around To Rearrange Chairs On The Titanic

We also think such moves implicitly reveal their company's views on the direction of future fiscal deficits in the US, and by extension, the belief that the financial burden will only increase on future generations.

Comment?

Related Topix: Walgreens, Retail, Medtronic, Medicine, Medical Equipment, Healthcare Industry, Pfizer, Biotech, AstraZeneca

Wed Jul 09, 2014

Barron's

Salix Pharmaceuticals: - Better Deal Than It Is Being Viewed'

On July 1, Salix Pharmaceuticals jumped 14% after announcing positive results from a drug trial .

Comment?

Related Topix: Biotech, Salix Pharmaceuticals, Medicine, Healthcare Industry, Medtronic, Medical Equipment, Pfizer, Raleigh, NC

BioSpace

Here's Why Pfizer Inc. Should Buy GlaxoSmithKline

In the aftermath of pharmaceutical giant Pfizer failing in its repeated attempts to acquire European drug maker AstraZeneca , investors may be wondering what's next.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, AstraZeneca

Tue Jul 08, 2014

BioSpace

Fund Manager Dumps Biggest Investment Into AstraZeneca PLC

Veteran life sciences investor Neil Woodford has put his money where his mouth is by choosing AstraZeneca as the single biggest investment for his new fund.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

Hispanic Business

AstraZeneca and Max Planck Institute announce research agreement to...

The satellite unit will focus on novel chemistry and chemical biology in areas of new modality chemistry such as stabilised peptides, macrocycles and conjugation chemistry.

Comment?

Related Topix: Biotech, Chemistry, Science

Sys-Con Media

AstraZeneca, Business Process Partner Genpact and Trintech Recognized ...

Trintech , a leading global provider of integrated software solutions for the Last Mile of Financea , announced today that its customer AstraZeneca received an Alsbridge Innovation Award for its balance sheet reconciliation transformation project.

Comment?

Related Topix: Biotech, Globecomm Systems, Cable & Satellite, Telecom, Alsbridge, Outsourcing

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••